Testimonials

Small Molecules

Biological Therapeutics

New Targets

Diagnostics

Enabling Technology

Antibody Catalogue

Register

Privileged Access Section

Anti-CD41 & CD61 Antibody Profile

Antigen: Integrin a2bß3 (CD41 & CD61)
Relevance: Integrins are heterodimeric cell surface receptors composed of a and ß subunits, which mediate cell-cell and cell-extracellular matrix attachments. Aberrant integrin expression has been found in many epithelial tumours. Changes in integrin expression have been shown to be important for the growth and early metastatic capacity of melanoma cells.  Integrin a2b (CD41) and integrin ß3 (CD61) associate to form the heterodimer integrin a2bb3 (CD41/CD61; GPIIb/IIIa), a fibronectin receptor expressed in platelets.  P256 has potential use for imaging of thrombi. P256 induces aggregation of normal platelets in plasma.
Clone: P256
Subclass: IgG1
Applications: Immunofluorescence, Immunoprecipitation, Western blot
Immunogen: Peripheral blood mononuclear cells
Reactivity: -
Species raised in: Mouse: Balb/c.
Fusion partner: P3-NS1/1-Ag4-1
Recommended growth conditions: DMEM + 5% FCS
References: Bai Y et al. 1983. Eur. J. Immunol. 13:521-527 PubMed Logo
Bachelot C et al. 1990. Eur. J. Biochem. 190:177-183 PubMed Logo
Notes: 135 kDa component of the glycoprotein IIa/IIIb complex on platelet and megakaryocytes cell membranes.

For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com

Please note that CRT supplies to distributors only.  However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information.

[back]